Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EVLO

Evelo Biosciences Inc

Nov 28 • 04:00PM ET

0.4100

Dollar change -0.0100
Percentage change -2.38	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-13.35	Insider Own	50.78%	Shs Outstand	18.93M	Perf Week	-28.12%
Market Cap	7.76M	Forward P/E	-	EPS next Y	-	Insider Trans	125.61%	Shs Float	9.32M	Perf Month	-25.47%
Income	-82.35M	PEG	-	EPS next Q	-	Inst Own	27.08%	Short Float / Ratio	4.61% / 0.62	Perf Quarter	-93.83%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	11.94%	Short Interest	0.43M	Perf Half Y	-86.15%
Book/sh	-1.42	P/B	-	EPS next Y	-	ROA	-153.98%	Target Price	10.00	Perf Year	-98.95%
Cash/sh	0.91	P/C	0.45	EPS next 5Y	-	ROE	-6232.76%	52W Range	0.30 - 45.60	Perf YTD	-98.73%
Dividend	-	P/FCF	-	EPS past 5Y	-4.69%	ROI	-	52W High	-99.10%	Beta	1.77
Dividend %	-	Quick Ratio	0.48	Sales past 5Y	0.00%	Gross Margin	-	52W Low	36.35%	ATR	0.18
Employees	66	Current Ratio	0.48	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	32.33	Volatility	22.88% 26.87%
Optionable	No	Debt/Eq	-	EPS Q/Q	87.43%	Profit Margin	-	Rel Volume	0.69	Prev Close	0.42
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 14 BMO	Payout	-	Avg Volume	693.41K	Price	0.41
Recom	5.00	SMA20	-5.69%	SMA50	-78.23%	SMA200	-91.87%	Volume	477,675	Change	-2.38%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-01-21	Upgrade	Chardan Capital Markets	Neutral → Buy	$12
Jun-23-21	Initiated	Cantor Fitzgerald	Overweight	$28
Apr-12-21	Upgrade	Jefferies	Hold → Buy	$11 → $18
Dec-23-20	Initiated	JMP Securities	Mkt Outperform	$27
May-21-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$8
May-12-20	Downgrade	Jefferies	Buy → Hold	$18 → $6
Apr-30-19	Initiated	Jefferies	Buy	$18
Jan-29-19	Initiated	Chardan Capital Markets	Neutral	$10

Nov-22-23 07:00AM	Flagship-backed microbiome biotech Evelo to shut down (BioPharma Dive)
Nov-14-23 03:57PM	FMR LLC Reduces Stake in Evelo Biosciences Inc (GuruFocus.com)
Nov-02-23 08:40AM	Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript (Insider Monkey) -19.35%
02:12AM	Q3 2023 Horizon Technology Finance Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-18-23 11:21AM	Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study (Zacks) -16.67%
09:52AM	Loading…
09:52AM	Arm initiated, SQM downgraded: Wall Street's top analyst calls (The Fly)
08:30AM	Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More (Zacks)
Oct-17-23 07:00AM	Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis (GlobeNewswire) -58.76%
Aug-14-23 07:30AM	Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights (GlobeNewswire) +28.63%
Aug-10-23 02:27PM	FMR LLC Acquires Significant Stake in Evelo Biosciences Inc (GuruFocus.com)
Jul-18-23 03:00AM	Moderna Co-Founders Firm Bought Up This Embattled Biotech Stock (Barrons.com) +61.69%
03:00AM	Moderna Co-Founder Bought Up This Embattled Biotech Stock (Barrons.com)
Jul-12-23 07:30AM	Evelo Biosciences Closes $25.5 Million Private Placement (GlobeNewswire)
Jul-10-23 07:30AM	Evelo Biosciences Announces $25.5 Million Private Placement (GlobeNewswire) +39.83%
Jun-29-23 09:00AM	Evelo Biosciences Announces Reverse Stock Split Effective (GlobeNewswire) -30.68%
12:00PM	Loading…
May-17-23 12:00PM	What Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock (Zacks)
May-16-23 06:00AM	Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry (PR Newswire)
May-10-23 08:42AM	Evelo Biosciences Insiders Added US$575k Of Stock To Their Holdings \ (Simply Wall St.) +11.82%
Apr-26-23 03:51PM	Evelo Biosciences' Atopic Dermatitis Study Cohort Misses Primary Goal Again, Shuts Study, Lays Off More Staff (Benzinga) -32.89%
03:37PM	Flagship-backed startup makes layoffs for second time in three months (American City Business Journals)
07:30AM	Evelo Biosciences Provides Clinical Updates (GlobeNewswire)
Mar-20-23 10:46PM	Evelo Biosciences, Inc. (NASDAQ:EVLO) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-16-23 10:23PM	Q4 2022 Evelo Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) -5.08%
07:00AM	Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights (GlobeNewswire)
Mar-09-23 06:00AM	Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 (GlobeNewswire)
Mar-01-23 09:35AM	After Plunging -40.39% in 4 Weeks, Here's Why the Trend Might Reverse for Evelo Biosciences, Inc. (EVLO) (Zacks) -6.11%
06:00AM	Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-27-23 06:00AM	Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial (GlobeNewswire)
Feb-13-23 09:35AM	Down -39.46% in 4 Weeks, Here's Why Evelo Biosciences, Inc. (EVLO) Looks Ripe for a Turnaround (Zacks)
Feb-01-23 01:56PM	Flagship-backed biotech cuts nearly half its staff (American City Business Journals) -25.11%
12:53PM	Loading…
12:53PM	Evelo Biosciences' Atopic Dermatitis Study Fails, Observes Unusually High Placebo Response Rates (Benzinga)
08:04AM	UPDATE 1-Evelo Biosciences to cut jobs, skin disease drug trial disappoints (Reuters)
07:30AM	Evelo Biosciences Provides Clinical and Business Updates (GlobeNewswire)
Jan-24-23 06:48AM	Daily Vickers Top Buyers & Sellers for 01/24/2023 (Argus Research)
Jan-11-23 04:15PM	Horizon Technology Finance Provides Fourth Quarter 2022 Portfolio Update (PR Newswire)
Dec-16-22 06:01AM	Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt (GlobeNewswire)
Dec-01-22 07:40AM	Evelo Biosciences, Inc. (NASDAQ:EVLO) insiders placed bullish bets worth US$575k in the last 12 months (Simply Wall St.) +5.74%
Nov-15-22 04:01PM	Evelo Biosciences Announces Publication of Scientific Basis for SINTAX Medicines in Frontiers in Immunology (GlobeNewswire)
Nov-14-22 05:27PM	Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights (GlobeNewswire)
Nov-08-22 06:00AM	Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference (GlobeNewswire)
Sep-07-22 01:00AM	Evelo Biosciences Presents Biomarker Data Demonstrating Anti-inflammatory Effects of EDP1815 in Psoriasis at the 2022 European Academy of Dermatology and Venereology (EADV) Congress (GlobeNewswire)
Sep-01-22 05:15PM	Evelo Biosciences Announces Grant of Inducement Award (GlobeNewswire)
06:00AM	Evelo Biosciences to Participate in Morgan Stanley 20th Annual Global Health Care Conference (GlobeNewswire)
Aug-11-22 11:00PM	Evelo Biosciences, Inc. (EVLO) Q2 2022 Earnings Call Transcript (Motley Fool)
06:01AM	Evelo Biosciences Announces Succession Plan (GlobeNewswire)
06:00AM	Evelo Biosciences Announces Second Quarter 2022 Financial Results and Business Highlights (GlobeNewswire)
Aug-08-22 09:33AM	What Type Of Shareholders Own The Most Number of Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares? (Simply Wall St.) +7.12%
Aug-05-22 06:00AM	Evelo Biosciences to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022 (GlobeNewswire)
Jul-18-22 06:00AM	Evelo Biosciences Announces Appointment of Marella Thorell as Chief Financial Officer (GlobeNewswire)
Jun-24-22 08:01AM	Bullish Evelo Biosciences, Inc. (NASDAQ:EVLO) insiders were rewarded last week as their US$575k investment inflated to US$799k (Simply Wall St.)
May-25-22 08:37AM	Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common Stock (GlobeNewswire) +23.29%
May-12-22 10:47AM	CORRECTION: Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights (GlobeNewswire) -9.66%
06:00AM	Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights (GlobeNewswire)
Apr-21-22 06:00AM	Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors (GlobeNewswire)
Apr-14-22 11:22AM	Read Why Did Evelo Discontinue EDP1867 Atopic Dermatitis Program (Benzinga)
06:00AM	Evelo Biosciences Provides Updated Guidance on Advancing Clinical Inflammation Programs (GlobeNewswire)
Apr-06-22 06:00AM	Evelo Biosciences Announces Appointments of Jose-Carlos Gutiérrez-Ramos and Tonya Williams to Board of Directors (GlobeNewswire)
Mar-26-22 12:00PM	Evelo Biosciences Presents Late-Breaking Oral Abstract on Data from Phase 2 Trial of EDP1815 in Psoriasis at 2022 American Academy of Dermatology Annual Meeting (GlobeNewswire)
Mar-24-22 01:30PM	Evelo Biosciences, Inc. (EVLO) Q4 2021 Earnings Call Transcript (Motley Fool) +25.99%
12:40PM	Evelo Biosciences Shares Gain After Positive Data On Faster Release EDP1815 Capsule, Q4 Earnings (Benzinga)
06:00AM	Evelo Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Business Highlights (GlobeNewswire)
Mar-17-22 07:00AM	Evelo Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 24, 2022 (GlobeNewswire)
Mar-07-22 06:00AM	Evelo Biosciences to Host KOL Discussion on Treatment Advances for All Stages of Psoriasis and Potential of SINTAX Medicines (GlobeNewswire)
Mar-02-22 08:50AM	Why Evelo Biosciences (EVLO) Might Surprise This Earnings Season (Zacks)
07:00AM	Evelo Biosciences to Participate in Cowen 42nd Annual Health Care Conference (GlobeNewswire)
Feb-28-22 09:00AM	Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs (PR Newswire) -8.36%
06:00AM	Durable and Deepening Clinical Responses Observed in Post-Treatment Period of Evelo Biosciences Phase 2 Clinical Trial of Oral EDP1815 in Psoriasis (GlobeNewswire)
Feb-24-22 07:55AM	5 Drug/Biotech Stocks Set to Outpace Q4 Earnings Estimates (Zacks) +15.95%
Feb-17-22 07:00AM	Evelo Biosciences Announces Dosing of First Patient in Phase 2 Trial of EDP1815 in Atopic Dermatitis (GlobeNewswire) -9.25%
Feb-15-22 10:05AM	INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT (PR Newswire)
Feb-11-22 12:00PM	Evelo Biosciences, Inc. (EVLO) Upgraded to Buy: Here's What You Should Know (Zacks) -5.80%
Feb-07-22 07:00AM	Evelo Biosciences Announces Highly Significant Reductions in Clinically Validated Inflammatory Cytokines in EDP1815 Phase 2 Psoriasis Trial (GlobeNewswire)
Jan-17-22 07:00AM	Evelo Biosciences Presents Data on EDP1815 Mechanism of Action and Supporting Ongoing Clinical Development for Inflammatory Diseases (GlobeNewswire)
Jan-04-22 07:00AM	Evelo Biosciences Announces Key 2022 Strategic Priorities and Upcoming Catalysts (GlobeNewswire)
Dec-14-21 07:00AM	Evelo Biosciences Added to Nasdaq Biotechnology Index (GlobeNewswire) -8.21%
Nov-09-21 07:00AM	Evelo Biosciences to Present at 2021 Jefferies London Healthcare Conference (GlobeNewswire)
Oct-28-21 07:01PM	Evelo Biosciences, Inc. (EVLO) Q3 2021 Earnings Call Transcript (Motley Fool)
07:00AM	Evelo Biosciences Reports Third Quarter 2021 Financial Results and Business Highlights (GlobeNewswire)
Oct-21-21 07:00AM	Evelo Biosciences to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021 (GlobeNewswire)
Oct-18-21 08:49AM	How Many Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares Do Institutions Own? (Simply Wall St.)
Oct-13-21 10:47AM	Wall Street Analysts Believe Evelo Biosciences, Inc. (EVLO) Could Rally 164%: Here's is How to Trade (Zacks) -9.32%
10:00AM	Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change (PR Newswire)
07:00AM	Evelo Biosciences Presents Preclinical Data for EDP1867 at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (GlobeNewswire)
Sep-29-21 03:37AM	48 Biggest Movers From Yesterday (Benzinga) -9.16%
Sep-28-21 12:38PM	36 Stocks Moving In Tuesday's Mid-Day Session (Benzinga) +7.41%
12:31PM	Evelo (EVLO) Posts Positive Data from Phase II Psoriasis Study (Zacks)
Sep-27-21 12:11PM	Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares Slide (Benzinga)
07:40AM	Evelo Biosciences Psoriasis Candidate Shows Benefit In Mid-Stage Study (Benzinga)
02:00AM	Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis; Confirms Ability to Harness the Small Intestinal Axis, SINTAX, to Treat Systemic Inflammatory Disease (GlobeNewswire)
Sep-20-21 07:00AM	Evelo Biosciences to Present at 2021 Cantor Global Healthcare Conference (GlobeNewswire) -13.79%
04:58AM	48 Biggest Movers From Friday (Benzinga)
Sep-09-21 07:00AM	Evelo Biosciences Announces Issuance of U.S. Patent for Pharmaceutical Compositions of Single Strains of Naturally Occurring Bacteria as Medicines (GlobeNewswire)
Sep-08-21 08:30AM	Implied Volatility Surging for Evelo Biosciences (EVLO) Stock Options (Zacks)
Sep-07-21 07:00AM	Evelo Biosciences Appoints Iain McInnes, M.B.Ch.B, Ph.D, to Board of Directors (GlobeNewswire)
Aug-06-21 08:46AM	Are Options Traders Betting on a Big Move in Evelo (EVLO) Stock? (Zacks)
Jul-31-21 05:31AM	Evelo Biosciences, Inc. (EVLO) Q2 2021 Earnings Call Transcript (Motley Fool)
Jul-29-21 07:00AM	Evelo Biosciences Reports Second Quarter 2021 Financial Results and Business Highlights (GlobeNewswire) +8.83%
Jul-22-21 07:00AM	Evelo Biosciences to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021 (GlobeNewswire) -22.71%
Jul-14-21 04:01PM	Evelo Biosciences Announces Grant of Inducement Award (GlobeNewswire) -8.75%
Jun-21-21 06:50PM	Should I Buy Evelo Biosciences, Inc. (EVLO)? (Insider Monkey)

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bodmer Mark	CSO, President of R&D	Nov 08	Sale	0.33	3,163	1,044	25,732	Nov 08 08:32 PM
McHale Duncan	Chief Medical Officer	Nov 08	Sale	0.33	3,103	1,024	16,984	Nov 08 08:32 PM
Thorell Marella	Chief Financial Officer	Nov 08	Sale	0.33	1,811	598	22,259	Nov 08 08:31 PM
GILL SIMBA	President & CEO	Nov 08	Sale	0.33	172	57	17,758	Nov 08 08:31 PM
McHale Duncan	Chief Medical Officer	Nov 02	Sale	0.33	6,854	2,262	13,587	Nov 03 04:11 PM
Bodmer Mark	CSO, President of R&D	Nov 02	Sale	0.33	6,854	2,262	22,270	Nov 03 04:12 PM
Thorell Marella	Chief Financial Officer	Nov 02	Sale	0.33	3,999	1,320	17,570	Nov 03 04:11 PM
GILL SIMBA	President & CEO	Sep 28	Sale	3.94	1,996	7,864	16,758	Sep 29 04:02 PM
McHale Duncan	Chief Medical Officer	Aug 08	Sale	9.51	3,434	32,657	7,941	Aug 09 08:42 PM
Bodmer Mark	CSO, President of R&D	Aug 08	Sale	9.51	3,128	29,747	16,624	Aug 09 08:44 PM
Thorell Marella	Chief Financial Officer	Aug 08	Sale	9.51	2,004	19,058	9,069	Aug 09 08:42 PM
GILL SIMBA	President & CEO	Aug 08	Sale	9.51	342	3,252	3,754	Aug 09 08:43 PM
Flagship Ventures Fund IV Gene	10% Owner	Jul 11	Buy	2.31	5,411,255	12,499,999	3,931,685	Jul 13 05:15 PM
Bodmer Mark	CSO, President of R&D	May 23	Sale	0.14	22,571	3,201	262,557	Jun 12 04:01 PM
Bodmer Mark	CSO, President of R&D	May 08	Sale	0.13	68,014	8,536	285,128	May 10 09:31 PM
McHale Duncan	Chief Medical Officer	May 08	Sale	0.13	66,730	8,375	97,516	May 10 09:32 PM
Thorell Marella	Chief Financial Officer	May 08	Sale	0.13	38,531	4,836	91,469	May 10 09:31 PM
GILL SIMBA	President & CEO	May 08	Sale	0.13	3,537	444	58,512	May 10 09:31 PM
CARRIERE STEPHEN J	Principal Accounting Officer	Jan 23	Sale	1.06	151	160	203	Jan 23 05:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EVLO

Evelo Biosciences Inc

Upgrade your FINVIZ experience